Future topics

To give potential applicants as much time as possible to form consortia and prepare their proposals, IMI regularly publishes information on possible future topics well in advance of the official Call launch. To ensure you get the latest information on forthcoming Calls, sign up to our newsletter, follow us on Twitter, or join our LinkedIn group.

Future Call dates

IMI’s next Calls for proposals are currently planned for early 2020. This date is indicative and may change.

Future IMI Calls for proposals

The following topics are under consideration for inclusion in future IMI Calls for proposals in the long term. The discussions on these topics are still in their early stages. For this reason, the topics may change considerably and they will probably not be ready for inclusion in an IMI Call for proposals for several months. Furthermore, as the discussions advance, it is likely that some topics will be added to this list while others will be dropped. In any case, we hope that this list will give potential applicants a useful glimpse into what is under development in the longer term, and provide additional time to enhance their network. We will update this list whenever we have updates on the status of the topics.

The list of topics under discussion is given below; more information on the draft topics can be found in this document.

Neurodegeneration and other neuroscience priorities

  • Digital endpoints and placebo effect in chronic pain

Infection control including vaccines

  • Development of innovative personalized diagnostics and patient-guided therapies for the management of sepsis-induced immune suppression

Big data, digital health, clinical trials and regulatory research

  • Data lakes


  • Prospective real-world clinical implementation of liquid biopsies
  • Tumour plasticity

Facilitating the translation of advanced therapies to patients in Europe

  • Optimising patient access to new therapies for rare diseases

List updated July 2019


All information regarding future IMI Call topics is indicative and subject to change. Final information about future IMI Calls will be communicated after approval by the IMI Governing Board.